Publication | Closed Access
PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML
190
Citations
19
References
2008
Year
Dual InhibitorHematological MalignancyMedicineAntileukemic ActivityMixed-phenotype Acute LeukemiaImmunologyMyeloid NeoplasiaCell DeathPharmacotherapyAnti-cancer AgentPharmacologyCell SignalingTumor BiologyClass Ia
| Year | Citations | |
|---|---|---|
Page 1
Page 1